Mon, 24 Oct 2016 12:28:07 GMT
Mon, 24 Oct 2016 07:07:37 GMT
Paragon Capital Management Ltd Lowers stake in AbbVie Inc (ABBV)
- Market DigestAbbVie
Inc (ABBV) : Paragon Capital Management Ltd reduced its stake in AbbVie
Inc by 3.46% during the most recent quarter end. The investment management company now holds a total of 9,775 shares of AbbVie
Inc which is valued at $601,651 after ...
Mon, 24 Oct 2016 03:00:00 GMT
Mon, 24 Oct 2016 02:48:45 GMT
Dividend Assets Capital LLC invests in AbbVie Inc. (ABBV) Shares
Dividend Assets Capital LLC boosted its stake in shares of AbbVie
Inc. (NYSE:ABBV) by 7.4% during the second quarter, Holdings Channel reports. The fund owned 5,106 shares of the company's stock after buying an additional 350 shares during the period.
Sun, 23 Oct 2016 21:04:28 GMT
AbbVie Inc. (ABBV) Stake Boosted by Alps Advisors Inc.
logo Alps Advisors Inc. raised its position in AbbVie
Inc. (NYSE:ABBV) by 14.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 443,246 shares of the company's stock ...
Sun, 23 Oct 2016 20:36:44 GMT
Is AbbVie Inc.(NYSE: ABBV), a large market cap stock a smart buy?
- The Daily Leicester
With a market cap of has a large market cap size. AbbVie
Inc. (NYSE: ABBV) has been on the stock market since its IPO date on the 1/2/2013. AbbVie
Inc. is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AbbVie
Sun, 23 Oct 2016 14:35:30 GMT
Top Health Care Earnings Coming Next Week
- 24/7 Wall St.
Earnings season is now in full swing, and we have put together a preview of some of the world's largest players in the health care sector. This current quarter ahead of the election could very well set a different direction for this sector, after it ...
Sun, 23 Oct 2016 14:18:00 GMT
Sun, 23 Oct 2016 11:35:00 GMT
Sun, 23 Oct 2016 09:42:34 GMT
Next Weeks Broker Price Targets For AbbVie Inc. (NYSE:ABBV)
- Fiscal Standard
09/08/2016 – AbbVie
Inc. was downgraded to “neutral” by analysts at JP Morgan. They now have a USD 73 price target on the stock. 09/06/2016 – AbbVie
Inc. had its “buy” rating reiterated by analysts at UBS. 09/01/2016 – Raymond James began new ...